ask="N/A"
ask_size="N/A"
average_daily_volume="16115"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="+0.05"
change_from_200_day_moving_average="0.43"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-2.25"
change_From_52_week_low="2.60"
change_in_percent="+0.88%"
close="5.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.42"
ebitda="-10.75M"
eps_estimate_current_year="-0.47"
eps_estimate_next_quarter="-0.12"
eps_estimate_next_year="-0.51"
ex_dividend_date="N/A"
float_shares="2879000"
high="5.70"
high_52_weeks="7.95"
last_trade_date="3/1/2017"
last_trade_price="5.70"
last_trade_size="1351"
last_trade_time="4:00pm"
low="5.50"
low_52_weeks="3.10"
market_capitalization="163.80M"
moving_average_200_day="5.27"
moving_average_50_day="5.66"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.88"
open="5.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+8.15%"
percent_change_from_50_day_moving_average="+0.69%"
percent_change_from_52_week_high="-28.30%"
percent_change_from_52_week_low="+83.87%"
previous_close="5.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="16.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28736000"
short_ratio="4.26"
stock_exchange="ASE"
symbol="OCX"
volume="10150"
weeks_range_52="3.10 - 7.95"
